Sensato Investors LLC boosted its stake in Syneron Medical Ltd. (NASDAQ:ELOS) by 168.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,000 shares of the medical equipment provider’s stock after buying an additional 35,800 shares during the period. Sensato Investors LLC owned about 0.16% of Syneron Medical worth $601,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of ELOS. Russell Investments Group Ltd. purchased a new stake in shares of Syneron Medical during the fourth quarter valued at approximately $409,000. State Street Corp boosted its stake in shares of Syneron Medical by 55.5% in the fourth quarter. State Street Corp now owns 71,591 shares of the medical equipment provider’s stock valued at $602,000 after buying an additional 25,553 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Syneron Medical by 96.1% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 31,247 shares of the medical equipment provider’s stock valued at $262,000 after buying an additional 15,312 shares during the last quarter. Oxford Asset Management boosted its stake in shares of Syneron Medical by 315.1% in the fourth quarter. Oxford Asset Management now owns 63,795 shares of the medical equipment provider’s stock valued at $536,000 after buying an additional 48,426 shares during the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of Syneron Medical during the fourth quarter valued at approximately $235,000. Hedge funds and other institutional investors own 69.17% of the company’s stock.
Shares of Syneron Medical Ltd. (ELOS) traded down 0.228% during mid-day trading on Tuesday, reaching $10.925. The company’s stock had a trading volume of 466,313 shares. The company’s 50-day moving average is $10.91 and its 200 day moving average is $10.00. Syneron Medical Ltd. has a 1-year low of $6.18 and a 1-year high of $11.43. The firm’s market capitalization is $381.26 million.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://sportsperspectives.com/2017/06/20/sensato-investors-llc-boosts-stake-in-syneron-medical-ltd-elos.html.
Separately, Maxim Group cut Syneron Medical from a “buy” rating to a “hold” rating and dropped their price target for the stock from $12.00 to $11.00 in a research report on Friday, May 12th.
About Syneron Medical
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.